Talphera (TLPH) Change in Account Payables (2010 - 2026)
Talphera's (TLPH) quarterly Change in Account Payables came in at $210000.0 in Q1 2026, up 160.87% year-on-year from $80500.0 in Q1 2025, and up 125.81% quarter-over-quarter from $93000.0 in Q4 2025.
Talphera (TLPH) Change in Account Payables (2010 - 2026) Analysis & Trends
Talphera's Change in Account Payables history runs 17 years deep, the most recent figure standing at $210000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 160.87% year-over-year to $210000.0 in Q1 2026; TTM through Mar 2026 was $347000.0, a 136.37% increase from a year earlier, with the FY2025 full-year figure at -$208000.0, up 69.0% from the prior year.
- Change in Account Payables climbed to $210000.0 in Q1 2026 per TLPH's latest filing, from $93000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $526000.0 in Q4 2022 and bottomed at -$774000.0 in Q2 2023.
- The 5-year median for Change in Account Payables is $37000.0 (2022), against an average of -$40764.7.
- Across the five-year window, Change in Account Payables soared 409.41% in 2022 and slumped 2191.89% in 2023, its largest moves.
- Year by year, Change in Account Payables stood at $526000.0 in 2022, then retreated by 27.38% to $382000.0 in 2023, then retreated by 28.27% to $274000.0 in 2024, then sank by 66.06% to $93000.0 in 2025, then jumped by 125.81% to $210000.0 in 2026.
- Per Business Quant, the three latest TLPH Change in Account Payables figures stand at $210000.0 (Q1 2026), $93000.0 (Q4 2025), and -$466000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | 210,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210,000.00 |
| Mar 31, 2026 | 210,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Jun 30, 2025 | 510,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Mar 31, 2025 | -345,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Dec 31, 2024 | 274,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Sep 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Jun 30, 2024 | -471,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Mar 31, 2024 | -62,000.00 |
| Dec 31, 2023 | 382,000.00 |
| Dec 31, 2023 | 382,000.00 |